Atila Non-Invasive Prenatal Test Kits
Description
Noninvasive prenatal testing (NIPT) is a method to assess the risk that the fetus will be born with certain genetic abnormalities. Most common NIPT is for aneuploidy of a chromosome which is caused by the presence of an extra or missing copy of a chromosome. The test primarily looks for Down syndrome (trisomy 21), Edwards Syndrome (trisomy 18), and Patau Syndrome (trisomy 13).
Atila also provides test kits for Gender Determination and Fetal Fraction, Fetal Fraction, and test for Genomic DNA Contamination in purified cfDNA.
Details
Key Features:
- Highly multiplexed PCR: Enables simultaneous quantification of 3 chromosomes
- Simple procedures: Direct ddPCR amplification on purified cfDNA
- Simple data analysis: No complicated bioinformatics required
Fetal fraction assay (FFA) can simultaneously quantify cfDNA and measure fetal fraction in the maternal blood cfDNA. The quantification derived from this assay can be then used for NIPT assay.
Key Features:
- Highly multiplexed PCR: Enables simultaneous quantification of fetal targets and a reference chromosome.
- Simple procedures: Direct ddPCR amplification on purified cfDNA
- Simple data analysis: Simple readout. No complicated bioinformatics required
Technical Specs:
- Sample Types: purified maternal cfDNA
- Assay Time: 3 hours
- Hands-On Time: 60 minutes
- System Compatibility: C1000 Touch Thermal Cycler, QX200 Droplet Reader
- Method: Multiplex ddPCRTM
*Order Information:
Cat. No. | Description | Size |
| NIPT-100 | NIPT kit for T21, T18, and T13 | 100 reactions |
| NIPT-FF-100 | NIPT Fetal Fraction Assay | 100 reactions |
| NIPT-Y-100 | NIPT Gender Determination and Fetal Fraction Assay | 100 reactions |
| NIPT-GS-100 | NIPT genomic DNA contamination test | 100 reactions |
* This product is for research use only in US